(Total Views: 203)
Posted On: 07/21/2022 4:52:17 PM
Post# of 1354
NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters New Contract Expected to Generate Significant 2023 Revenue, Drive Accelerated Future Growth
Pressure BioSciences (OTCQB: PBIO) (“PBI”) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty testing services to the worldwide nutraceuticals, biotherapeutics and other industries. The company today announced its entry into an agreement with North Star Holdings (“NSH”) on the financial partnership for the development, production, distribution and commercial roll-out of NSH’s novel, effectively water-soluble, nanoemulsified CBD spray for topical use. In addition, PBI will partner with the NSH team on the development and distribution of additional nano-CBD containing products that the highly successful Colorado cannabis operator has already suggested. “John’s years of experience in the cannabis space, his highly successful and vertically-integrated state-wide enterprise, and his company’s rapid growth over the past seven years to nearly $20 million in annual revenue is very impressive,” said Richard T. Schumacher, president and CEO of PBI, speaking of NSH and its president and CEO John Kaweske. “John has already delivered highly valuable perspectives and strategies that we believe will help NSH get their new nano-CBD topical product to market faster and more efficiently than could have happened had we partnered with anyone else. This is a tremendous opportunity for both NSH and PBI, one that we believe will generate several million dollars in annual revenues for PBI in 2023, with exciting, accelerating growth into the future.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Pressure BioSciences (OTCQB: PBIO) (“PBI”) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty testing services to the worldwide nutraceuticals, biotherapeutics and other industries. The company today announced its entry into an agreement with North Star Holdings (“NSH”) on the financial partnership for the development, production, distribution and commercial roll-out of NSH’s novel, effectively water-soluble, nanoemulsified CBD spray for topical use. In addition, PBI will partner with the NSH team on the development and distribution of additional nano-CBD containing products that the highly successful Colorado cannabis operator has already suggested. “John’s years of experience in the cannabis space, his highly successful and vertically-integrated state-wide enterprise, and his company’s rapid growth over the past seven years to nearly $20 million in annual revenue is very impressive,” said Richard T. Schumacher, president and CEO of PBI, speaking of NSH and its president and CEO John Kaweske. “John has already delivered highly valuable perspectives and strategies that we believe will help NSH get their new nano-CBD topical product to market faster and more efficiently than could have happened had we partnered with anyone else. This is a tremendous opportunity for both NSH and PBI, one that we believe will generate several million dollars in annual revenues for PBI in 2023, with exciting, accelerating growth into the future.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)
